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AbStRACt
Background: Sleep disordered breathing occurs in over half of 
the estimated 5.1 million people in the United States diagnosed 
with heart failure. 
Aim and Methods: The purpose of this integrative review is 
to find evidence for the routine use of a sleep apnea screening 
protocol in patients with heart failure. 
Results: Several useful tools are described including the 
Epworth Sleepiness Scale, the STOP BANG questionnaire and 
the Berlin questionnaire. Using one of these tools along with 
an overnight pulse oximetry is a cost effective way to screen 
patients before the more costly sleep studies. 
Conclusions: Evidence shows that treatment of sleep apnea 
in this population decreases not only morbidity and mortality 
rates, but the overall cost burden of the disease as well. 
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How this fits with quality in primary care
What do we know?
Heart failure patients are at risk for sleep apnea. This sleep disordered breathing may affect their survival and quality of life. 
Sleep studies are ordered as needed, but can be expensive.
What does this paper add
Describes the types of sleep apnea, the variety of screening tools for sleep apnea and provides evidence for advising providers 
to screen all patients with heart failure for sleep apnea with both a screening tool and pulse oximetry before ordering the gold 
standard sleep study.
Introduction 
According to the Centers for Disease Control (CDC) 
approximately 5.1 million people in the United States have a 
diagnosis of heart failure and half will die within five years of 
diagnosis.1 Heart failure is characterized by its high mortality, 
frequent hospitalizations and a reduced quality of life with 
estimates of costs to the nation reach $37 billion each year.2 There 
is accumulating evidence that nocturnal breathing disorders are 
important modifiers of disease progression in patients with heart 
failure. Sleep-disordered breathing, or sleep apnea is the most 
common comorbidity in heart failure patients, occurring in over 
half of heart failure patients and can exacerbate the illness.3,4 
Review of the Literature
A review of the literature using the keywords heart failure, 
sleep apnea, treatment, and screening in the CINAHL and 
PubMed databases was completed. Research studies that 
evaluated apnea screening and/or treatment were reviewed. 
Three major treatment modalities and three screening tools 
emerged for both types of sleep-disordered breathing.
 Sleep apnea is defined as a combination of hypopnea (slow, 
shallow breathing for 10 seconds or more) and apnea (cessation 
of breathing for 10 seconds or more) that results in a decrease 
in blood oxygen saturation.5 Improving morbidity and mortality 
in heart failure patients involves assessing factors such as sleep 
disordered breathing that impact the progression of the disease. 
Several types of sleep-disordered breathing have been identified 
in the heart failure population including obstructive sleep apnea, 
central sleep apnea, and complex sleep apnea syndrome. 6,4
Types of Sleep Apnea
Obstructive sleep apnea affects approximately 35% of heart 
failure patients and is caused by partial or complete collapse or 
obstruction of the upper airway.4 It causes a change in intra-
thoracic pressure and an increased sympathetic drive resulting in 
a cascade of physiological changes including decreased cardiac 
output, increased myocardial oxygen demand, vasoconstriction, 
hypertension, and activation of the renal renin-angiotensin 
system.
Central sleep apnea is more complex and difficult to treat, 
as its cause is the temporary withdrawal of the brainstem-
driven respiratory drive.4 A distinct pattern of Cheyne-Stokes 
respiration is present in central apnea or hypopnea followed 
by hyperventilation in a cyclic crescendo-decrescendo pattern 
resulting in an oscillation of arterial carbon dioxide above and 
below the threshold for apnea. 
 Complex sleep apnea involves repeated episodes of central 
apnea during treatment with CPAP in patients who initially 
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present with obstructive apnea. It is more difficult to treat 
and may need a higher level of ventilator support than CPAP 
such as adaptive sero-ventilation.7 Identification of the type of 
sleep apnea and treatment in heart failure patients is critical to 
improving the outcomes. 8
Continuous Positive Airway Pressure (CPAP)- The effects 
of CPAP is a continuous, low-level end-expiratory pressure to 
helps maintain an open airway as treatment for sleep-disordered 
breathing. A meta-analysis determined that CPAP improves 
left ventricular function (LVEF) in those patients with both 
obstructive sleep apnea and documented heart failure.9 
Bi-level Positive Airway Pressure (BiPAP) -The benefit 
of this therapy is that it adds additional respiratory support to 
the existing CPAP adding a set level of inspiratory pressure 
administered with each breath. Khayat et al. (2008) compared 
the use of CPAP in treatment of obstructive sleep apnea to the 
use of BiPAP in improving stable systolic dysfunction heart 
failure patients and found it to be superior to CPAP in increasing 
left ventricular function.13 
Adaptive Servoventilation (ASV) -Adaptive 
servoventilation (dynamic BiPAP) adjusts the inspiratory 
support component according to the needs of the patient. 
Although CPAP has been shown to improve cardiac function in 
heart failure patients with sleep apnea, it has been unsuccessful 
in suppressing central sleep apnea in nearly 50% of treated 
patients.14 Research supports the use of ASV for the suppression 
of central sleep apneas as well as mixed apneas in the heart 
failure patient. Arzt et al. (2008) studied heart failure patients 
with central and complex sleep apneas and, ASV was found to 
have the greatest reduction in the apnea (Table 1).17
Screening Tools 
Several screening tools have been designed to identify sleep 
apnea in a variety of populations. A review of the literature with 
specific emphasis on diagnosing sleep apnea in the heart failure 
population revealed three tools most commonly used: the 
Epworth Sleepiness Scale, the STOP-Bang Equivalent Model, 
and the Berlin Questionnaire (Appendices 1-3). 
1. Epworth Sleepiness Scale (ESS) A review by Rosenthal 
& Dolan (2008) to assess the sensitivity of the ESS in identifying 
obstructive sleep apnea was conducted on patients screened 
with the tool with a subsequent sleep study.18 Epworth scores 
were analyzed in comparison to apnea index greater than or 
equal to five and it was determined that the screening tool alone 
had a fair discriminatory ability as a screener for obstructive 
sleep apnea. 
2. The STOP-Bang model was considered the simplest 
to use and score. A systematic review of obstructive sleep 
apnea screening questionnaires by reviewed 10 studies aimed 
at screening for SDB concluded that such screening tools 
are associated with promising results.19 Farney et al. (2011) 
conducted a study using the STOP-Bang Equivalent model 
(SBM) and its ability to predict obstructive sleep apnea in 
comparison to the sleep study to further classify obstructive 
sleep apnea into categories ranging from none to severe.20 With 
STOP-Bang scores of 6-8 there was a high probability of being 
diagnosed with obstructive sleep apnea via sleep study. 
3. The Berlin Questionnaire (BQ) sleep apnea screening 
tool was evaluated as to its sensitivity and specificity compared 
to the gold standard PSG sleep study as a diagnostic tool. A 
retrospective review of 130 sleep-clinic patients to determine 
its effectiveness found the BQ to have moderate specificity and 
low sensitivity in correctly diagnosing sleep apnea.21 A meta-
analysis of multiple screening tests for obstructive sleep apnea 
found the Berlin Questionnaire to be one of the most accurate 
questionnaires.22 
Combining both a sleep-screening tool and overnight 
pulse oximetry has proven useful. Garner & Traverse (2014) 
implemented an evidence-based protocol to screen for sleep apnea 
in a heart failure disease management clinic.23 Utilizing a screening 
tool, and overnight pulse oximetry test was clinically beneficial and 
cost effective in this population. Another study found significantly 
favorable results in diagnosing apnea after confirmation by sleep 
study, in their patient population when compared to using the 
screening tool alone.23 It was noted however, a high number of false 
negatives were found with all screens, including the BQ with the 
least accurate screen thought to be the ESS due to the plethora of 
other causative factors for daytime sleepiness.21,22
Treatment Type Mechanism Benefits described in research
Continuous Positive Airway 
Pressure (CPAP)
A continuous, low-level end-
expiratory pressure that helps 
maintain an open airway as 
treatment for sleep-disordered 
breathing. Sun et al. 2013
Improved overall health9
Reduced risk of hospitalizations & death10, 11
Improved left ventricular function & cardiac efficiency9,12
Heart transplant free survival Arzt12
Bi Level Positive Airway Pressure 
(BiPAP)
Adds additional respiratory 
support to the existing CPAP 
adding a set level of inspiratory 
pressure administered with each 
breath. Khayat et al. (2008)
Improves stable systolic dysfunction heart failure 
patients13
Superior to CPAP in increasing left ventricular function13
Adaptive Servoventilation (ASV)
Adjusts the inspiratory support 
component according to the needs 
of the patient.
(Sharma et al., 2012).
Improves cardiac function in heart failure patients with 
sleep apnea. Suppresses central sleep apnea and complex 
mixed apneas14,15
Improved exercise tolerance14
Positive effect on renal function16
Table 1: Types of Respiratory Support for Sleep Apnea.
 The Importance of Screening for Sleep Apnea in the Heart Failure Population 10
Synthesis of the Evidence 
This review supports the need for screening, diagnosis, 
and treatment of sleep-disordered breathing in the heart failure 
population. Untreated severe sleep disordered breathing has 
been found to have a statistically significant increased risk of 
all cause mortality. 24 Although using an overnight sleep study 
in a sleep lab is considered the gold standard for diagnosis of 
sleep-disordered breathing, such a study can be time-consuming 
and costly. 
Evidence-based screening tools such as The Epworth 
Sleepiness Scale (ESS) (Appendix 2), which measure subjective 
daytime sleepiness, or The STOP-Bang Questionnaire 
(Appendix 3), which assesses risk factors for obstructive sleep 
apnea, should be used to screen those at highest risk for sleep-
disordered breathing in the heart failure population. Despite the 
research consensus that such screens have inconsistencies and 
a high rate of false-positive results, when used in conjunction 
with a secondary screen of higher sensitivity and specificity 
such as overnight oximetry identification of patients with a 
true diagnosis of sleep apnea becomes more likely.18,20,21&25 
These patients could then be referred for a formal sleep study 
if needed to confirm or refute sleep apnea based on a positive, 
multi-leveled screen. 
Healthcare insurance companies are more likely to cover 
the cost of sleep studies in the presence of an oximetry study 
indicative of periods of hypoxia. Later confirmation of suspected 
diagnosis through PSG, the gold standard, has proven this 
screening protocol to be an effective method for identifying and 
diagnosing sleep apnea in the heart failure population.23 Once 
the long-term goal of complete protocol screening has been 
implemented and treatment instituted, long-term compliance 
with sleep apnea treatment can be reinforced by noting the 
patients verbalization of improved symptoms, improved 
screening scores, or by means of repeat echocardiogram 
(ECHO) which could possibly show documented improvement 
of heart function. 
Garner & Traverse (2013) studied the health behaviors and 
sleep apnea treatment adherence in the heart failure patient and 
found that non-compliance was highest in the elderly and in 
women for various reasons such as the prospect of an overnight 
sleep study outside of the home, being “too old” for evaluation 
and treatment, complications with other diagnoses, and cost.27 
For those who underwent PSG evaluation; but did not comply 
with the recommended CPAP treatment, common reasons 
given were mask intolerance, claustrophobia, and drying of 
the nose.27 Ongoing disease education plays a large factor in 
addressing not only the modifiable risk factors for heart failure 
as a disease. The resulting compliance to treatment greatly 
impacts quality of life, heart failure disease progression, and 
ultimately morbidity and mortality.28
Discussion and Conclusion 
The implementation and use an evidence-based sleep apnea 
screening tool, in conjunction with overnight pulse oximetry 
studies for those who are scored as high risk helps screen at risk 
patients before the more expensive sleep study and diagnosis 
of a sleep disordered breathing condition. Sleep apnea in the 
heart failure population should be approached as a co-existing 
chronic disease requiring long-term management. 
The American Heart Association guidelines state that 
“Continuous positive airway pressure can be beneficial to 
increase LVEF and improve functional status in patients with 
heart failure and sleep apnea” 30
Unfortunately, sleep apnea is not part of the routine evaluation 
and management of heart failure, so it remains untreated in 
most patients. Medical providers can play an instrumental role 
in screening and identifying those patients at highest risk for 
sleep apnea using an evidence-based screening protocol. Once 
identified and diagnosed, providers can reinforce the need for 
disease management and construct an individualized educational 
plan to increase adherence with recommended therapies.
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